Lukić ML - Search Results

1

[Interleukin-33/ST2: a new signaling pathway in immunity and immunopathology].

Pavlović S, Zdravković N, Radosavljević G, Arsenijević N, Lukić ML, Jovanović I. Pavlović S, et al. Among authors: lukic ml. Vojnosanit Pregl. 2012 Jan;69(1):69-77. doi: 10.2298/vsp1201069p. Vojnosanit Pregl. 2012. PMID: 22397299 Review. Serbian. No abstract available.

2

Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin.

Zdravkovic N, Shahin A, Arsenijevic N, Lukic ML, Mensah-Brown EP. Zdravkovic N, et al. Among authors: lukic ml. Mol Immunol. 2009 Nov;47(1):28-36. doi: 10.1016/j.molimm.2008.12.023. Epub 2009 Apr 7. Mol Immunol. 2009. PMID: 19356801

3

ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma.

Jovanovic I, Radosavljevic G, Mitrovic M, Juranic VL, McKenzie AN, Arsenijevic N, Jonjic S, Lukic ML. Jovanovic I, et al. Among authors: lukic ml. Eur J Immunol. 2011 Jul;41(7):1902-12. doi: 10.1002/eji.201141417. Eur J Immunol. 2011. PMID: 21484786 Free PMC article.

4

IL-33/ST2 axis in inflammation and immunopathology.

Milovanovic M, Volarevic V, Radosavljevic G, Jovanovic I, Pejnovic N, Arsenijevic N, Lukic ML. Milovanovic M, et al. Among authors: lukic ml. Immunol Res. 2012 Apr;52(1-2):89-99. doi: 10.1007/s12026-012-8283-9. Immunol Res. 2012. PMID: 22392053 Review.

5

IL-33/ST2 axis in innate and acquired immunity to tumors.

Jovanovic IP, Pejnovic NN, Radosavljevic GD, Arsenijevic NN, Lukic ML. Jovanovic IP, et al. Among authors: lukic ml. Oncoimmunology. 2012 Mar 1;1(2):229-231. doi: 10.4161/onci.1.2.18131. Oncoimmunology. 2012. PMID: 22720252 Free PMC article.

6

Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype.

Milovanovic M, Volarevic V, Ljujic B, Radosavljevic G, Jovanovic I, Arsenijevic N, Lukic ML. Milovanovic M, et al. Among authors: lukic ml. PLoS One. 2012;7(9):e45225. doi: 10.1371/journal.pone.0045225. Epub 2012 Sep 18. PLoS One. 2012. PMID: 23028861 Free PMC article.

7

ST2 gene-deletion reveals a role of Foxp3+ regulatory T cells in diabetes modulation in BALB/c mice.

Zdravkovic N, Pavlovic S, Zdravkovic V, Pejnovic N, Arsenijevic N, Lukic ML. Zdravkovic N, et al. Among authors: lukic ml. Transl Res. 2013 Feb;161(2):118-29. doi: 10.1016/j.trsl.2012.10.005. Epub 2012 Nov 8. Transl Res. 2013. PMID: 23142275

8

Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.

Jovanovic IP, Pejnovic NN, Radosavljevic GD, Pantic JM, Milovanovic MZ, Arsenijevic NN, Lukic ML. Jovanovic IP, et al. Among authors: lukic ml. Int J Cancer. 2014 Apr 1;134(7):1669-82. doi: 10.1002/ijc.28481. Epub 2013 Oct 10. Int J Cancer. 2014. PMID: 24105680

9

IL-33 receptor (ST2) deficiency downregulates myeloid precursors, inflammatory NK and dendritic cells in early phase of sepsis.

Babic ZM, Zunic FZ, Pantic JM, Radosavljevic GD, Jovanovic IP, Arsenijevic NN, Lukic ML. Babic ZM, et al. Among authors: lukic ml. J Biomed Sci. 2018 Jul 12;25(1):56. doi: 10.1186/s12929-018-0455-z. J Biomed Sci. 2018. PMID: 30001716 Free PMC article.

10

Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity.

Radosavljevic G, Jovanovic I, Majstorovic I, Mitrovic M, Lisnic VJ, Arsenijevic N, Jonjic S, Lukic ML. Radosavljevic G, et al. Among authors: lukic ml. Clin Exp Metastasis. 2011 Jun;28(5):451-62. doi: 10.1007/s10585-011-9383-y. Epub 2011 Mar 26. Clin Exp Metastasis. 2011. PMID: 21442355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters